OsNF-YAs suppress JA signaling. حسب Xiaoxiang Tan (12542842)

الموضوعات:

TAD motif of OsMYC3 is required for interaction with OsMED25 or OsNF-YAs. حسب Xiaoxiang Tan (12542842)

الموضوعات:

Effects of exogenous JA on RSV-infected <i>OE-OsNF-YA2</i> transgenic lines. حسب Xiaoxiang Tan (12542842)

الموضوعات:

Different effects of intervention: We simulate an intervention that decreases the nosocomial transmission rate by a factor of 70% (<i>β</i>→0.3<i>β</i>) starting from January 2011.... حسب Tal T. Robin (17847380)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. حسب Orna Mizrahi-Man (42539)

Manhattan plot that shows the location of genes involved in folate, homocysteine, and transsulfuration pathways for which we observed, from hybrid analyses, a significantly decreased risk of obstructive heart defects when the risk variant was paternally-derived compared to maternally-derived, The National Birth Defects Prevention Study, USA, October 1997–August 2008 births. حسب Jenil Patel (10271373)

"…<p>Manhattan plot that shows the location of genes involved in folate, homocysteine, and transsulfuration pathways for which we observed, from hybrid analyses, a significantly decreased risk of obstructive heart defects when the risk variant was paternally-derived compared to maternally-derived, The National Birth Defects Prevention Study, USA, October 1997–August 2008 births.…"

CRISPR/Cas9-induced <i>OsSWEET14</i> promoter modification in TBR225 rice. حسب Phuong Nguyen Duy (11414117)

Patient visit inclusion and exclusion criteria, analysis of qSOFA <2 and qSOFA≥2. حسب Brian Rice (4393609)

Trends in sepsis management and sepsis mortality, 2012–2019, qSOFA≥2. حسب Brian Rice (4393609)

Annual emergency unit visits with suspected infection, qSOFA scores and malaria by year, 2010–2019. حسب Brian Rice (4393609)

Proportions and comparative mortality for sub-populations of septic (qSOFA≥2) patients, 2010–2019. حسب Brian Rice (4393609)

Proportions and comparative mortality for sub-populations of septic (qSOFA≥1) patients, 2010–2019. حسب Brian Rice (4393609)

Patient visit inclusion and exclusion criteria. حسب Brian Rice (4393609)

Logistic regression model of mortality in septic (qSOFA≥1) patients without malaria: 2012–2019 (N = 5,323). حسب Brian Rice (4393609)

Characteristics of non-septic (qSOFA = 0) and septic (qSOFA≥1) emergency unit patients with suspected infections (N = 17,490). حسب Brian Rice (4393609)

Annual predicted and observed mortality in septic (qSOFA≥1) patients without malaria, 2012–2019. حسب Brian Rice (4393609)

Interventions and mortality for patients 2012–2019 stratified by qSOFA score (n = 13,548). حسب Brian Rice (4393609)

Trends in sepsis management and sepsis mortality, 2012–2019. حسب Brian Rice (4393609)

Annual emergency unit visits with suspected infection, qSOFA scores and malaria by year, 2010–2019. حسب Brian Rice (4393609)

Annual predicted and observed mortality in septic (qSOFA≥2) patients without malaria, 2012–2019. حسب Brian Rice (4393609)